In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Marilina García-ArandaB-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0003-3759-4044 Desireé Martín-GarcíaB-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
Janire Gallejones-EskubiRed de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Vicente PortugalBiobizkaia Health Research Institute, Plaza Cruces s/n, 48903 Barakaldo, Spain.
Marta Jiménez-ToscanoSpanish Early-Onset Colorectal Cancer Consortium, Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0002-5970-426X Maria Jose LegarretaRed de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-1778-5196 José María QuintanaRed de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Maximino RedondoB-14 Research Group on Translational Research and Health Outcomes in Cancer and Chronic Diseases, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
Urko AguirreRed de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-8049-3030 REDISSEC/CARESS-CCR Group
Funding
Basque Health Department 2018111036Instituto de Salud Carlos III PI18/001181, PI21/00252, PI13/01692, PI18/01589, PI21/00674
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancer survivorshipcause-specific mortalitycolorectal cancerlong-term outcomessex differences
Identifiers
PMID42279250
PMCPMC13258410
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390